Atlas Trials

Anwaar Saeed

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Anwaar Saeed

RecordFirmDate
9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY) (NCT06896188)Anwaar Saeed2025-09-22
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA) (NCT06698250)Anwaar Saeed2024-12-18
Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer (NCT06006923)Anwaar Saeed2024-06-26
9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma (NCT05239182)Anwaar Saeed2022-01-26
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies (NCT03539822)Anwaar Saeed2018-10-22

Track Anwaar Saeed automatically

Every clearance here is in the API, with alerts when new ones post.